Mondelez International, Inc. (MDLZ)

Key Updates

Mondelez International has delivered a decisive earnings catalyst, with shares advancing 2.96% to $64.42 since the July 28 report ($62.57), following a stronger-than-expected Q2 2026 earnings release filed the same day. The company reported Q2 revenue of $9.36 billion and adjusted EPS of $0.73, both exceeding analyst consensus, while raising its full-year organic net revenue growth outlook to at least 2%. The stock's YTD gain now stands at 19.67%, cementing a sustained recovery from the mid-year lows and establishing a new multi-month high.

Current Trend

MDLZ has now posted consecutive gains across all tracked timeframes — 1d (+3.10%), 5d (+5.85%), 1m (+7.10%), 6m (+12.41%), and YTD (+19.67%) — reflecting a broad-based and accelerating uptrend. The stock has progressively reclaimed key levels: from the July 2 trough of $59.35, through the June 24 resistance of $61.96 (broken convincingly in late July), and now extending to $64.42. The earnings-driven gap higher on July 28 marks the most significant single catalyst of the year, with the after-hours print of $64.20 (+2.8%) confirmed and exceeded in regular trading. The trend structure is constructive, with higher lows and higher highs established since early July.

Investment Thesis

The core thesis for MDLZ rests on four pillars: (1) resilient global demand for branded snack foods across diversified geographies; (2) demonstrated pricing power and volume recovery supporting organic revenue growth; (3) robust free cash flow generation (~$3 billion guided for FY2026) underpinning capital returns; and (4) improving earnings quality, as evidenced by adjusted EPS outperformance and raised guidance. The company's geographic diversification — with material exposure to high-growth emerging markets in Latin America and Asia, Middle East & Africa — provides a structural offset to softness in mature markets such as Europe.

Thesis Status

The investment thesis has materially strengthened following the Q2 2026 results. All four thesis pillars received positive confirmation: revenue beat consensus ($9.36B vs. $9.21B expected), adjusted EPS exceeded estimates ($0.73 vs. $0.68), free cash flow guidance was reaffirmed at ~$3 billion, and the full-year organic revenue growth outlook was upgraded. The 19.67% YTD gain reflects increasing market conviction in the thesis. The primary remaining risk is the 1% revenue decline in Europe, which warrants monitoring but is currently offset by strong EM momentum. The thesis is on track and the risk/reward profile has improved relative to prior reports.

Key Drivers

The following factors are driving current price action and the investment outlook:

• Q2 2026 Earnings Beat: Revenue of $9.36 billion exceeded the $9.21 billion analyst consensus, and adjusted EPS of $0.73 surpassed the $0.68 estimate. Net income surged to $1.55 billion ($1.20/share) from $641 million ($0.49/share) in the prior-year period. — Morningstar, July 28, 2026
• Raised Full-Year Guidance: Mondelez lifted its organic net revenue growth outlook to at least 2% (from flat to 2% previously), while reaffirming ~$3 billion in free cash flow and flat-to-+5% adjusted EPS growth on a constant currency basis. — Wall Street Journal, July 28, 2026
• Latin America Outperformance: The region delivered 15% revenue growth to $1.37 billion, serving as the primary engine of Q2 growth and validating the company's emerging market diversification strategy. — Morningstar, July 28, 2026
• Asia, Middle East & Africa Growth: The AMEA segment posted 8.2% revenue growth, further reinforcing the EM growth narrative and reducing dependence on slower-growth developed markets. — Morningstar, July 28, 2026
• Regulatory Disclosure Compliance: The concurrent filing of Form 10-Q and Form 8-K on July 28, 2026 ensures full regulatory transparency, reducing information asymmetry risk for investors. — SEC EDGAR, July 28, 2026

Technical Analysis

MDLZ is trading at $64.42, its highest level in the current YTD recovery. The stock has now cleared the prior resistance zone around $62.57 (the July 28 close) and the psychological $63–$64 range, with the earnings catalyst providing volume-backed confirmation of the breakout. The progression of key levels — $59.35 (July 2 low) → $60.91 (July 6) → $62.57 (July 28) → $64.42 (current) — defines a clear ascending structure. Near-term support is established at $62.57, with secondary support at $61.96 (the June 24 high, now a confirmed support level). The 19.67% YTD gain and consistent momentum across all timeframes (1d through 6m) indicate a well-supported uptrend with no technical deterioration visible in the provided data. The next meaningful resistance level is not defined by the available data, suggesting the stock is in price discovery territory above recent highs.

Bull Case

• Guidance Upgrade Signals Management Confidence: The decision to raise the full-year organic net revenue growth floor to at least 2% — versus the prior flat-to-2% range — reflects management's increased conviction in demand durability through the remainder of FY2026. This is the most direct fundamental positive signal available. — Wall Street Journal, July 28, 2026
• Adjusted EPS Outperformance Demonstrates Operational Leverage: Adjusted EPS of $0.73 exceeded the $0.68 consensus by 7.4%, indicating that cost discipline and pricing power are translating into above-expectation bottom-line delivery, a key quality signal for institutional investors. — Morningstar, July 28, 2026
• Emerging Market Revenue Acceleration: Latin America's 15% growth and AMEA's 8.2% growth provide structural revenue tailwinds from geographies with favorable demographic and consumption trends, diversifying the company away from stagnant European demand. — Morningstar, July 28, 2026
• ~$3 Billion Free Cash Flow Guidance Reaffirmed: The maintenance of the ~$3 billion FCF target alongside raised revenue guidance suggests improving cash conversion and supports the company's capacity for dividends, buybacks, and debt management. — Morningstar, July 28, 2026
• Revenue Beat Across Multiple Segments: Total Q2 revenue of $9.36 billion exceeded the $9.21 billion consensus, with North America also contributing 3% growth, demonstrating that the outperformance is not solely dependent on EM momentum. — Morningstar, July 28, 2026

Bear Case

• European Revenue Decline Represents a Structural Headwind: Europe posted a 1% revenue decline in Q2 2026, a notable drag given the region's historical significance to Mondelez's revenue base. Persistent weakness in this segment could limit overall organic growth and weigh on profitability if the trend extends. — Morningstar, July 28, 2026
• Adjusted EPS Growth Guidance Remains Modest: The reaffirmed adjusted EPS growth outlook of flat to +5% on a constant currency basis represents a limited earnings expansion range, suggesting that margin improvement or earnings acceleration beyond this band is not anticipated by management at this time. — Morningstar, July 28, 2026
• Broader Macroeconomic Uncertainties Acknowledged: The WSJ report explicitly notes that the guidance increase was issued "despite broader macroeconomic uncertainties," indicating that management and the market recognize unquantified macro risks that could impair demand, particularly in consumer discretionary-adjacent categories. — Wall Street Journal, July 28, 2026
• Constant Currency Caveat Masks FX Exposure: The EPS growth guidance is expressed on a constant currency basis, implying that actual reported EPS growth could be materially lower depending on USD strength against key EM currencies (BRL, INR, etc.), where the company is increasingly generating revenue. — Morningstar, July 28, 2026
• Post-Earnings Rally Elevates Valuation Risk: With MDLZ up 19.67% YTD and the stock in price discovery territory above recent highs, the risk of a valuation-driven pullback increases if subsequent quarters fail to sustain the Q2 beat-and-raise cadence. The stock has no defined technical resistance above $64.42 based on available data. — Wall Street Journal, July 28, 2026